ABEO — Price & Float Short

—— Fair value ★ EPS beat ★ EPS miss —— Target Price

Float Short %

33.31

Margin Of Safety %

Put/Call OI Ratio

0.22

EPS Next Q Diff

-0.04

EPS Last/This Y

-2.29

EPS This/Next Y

0.74

Price

2.29

Target Price

15.56

Analyst Recom

Performance Q

-61.74

Upside

-1,796.5%

Beta

1.5

Ticker: ABEO

22 items of 1

Date	Symbol	Latest	P/C OI	P/C Vol	Total OI
2026-10-14	ABEO	4.38	0.39	7.89	22544
2026-10-15	ABEO	4.66	0.39	0.09	22522
2026-10-16	ABEO	4.43	0.39	2.73	22582
2026-10-19	ABEO	4.41	0.40	1.77	21801
2026-10-20	ABEO	4.61	0.40	0.99	21799
2026-10-21	ABEO	4.52	0.40	15.56	22009
2026-10-22	ABEO	4.47	0.40	0.00	22019
2026-10-23	ABEO	4.41	0.40	0.22	22128
2026-10-26	ABEO	4.32	0.40	12.90	22094
2026-10-27	ABEO	4.47	0.40	29.57	22216
2026-10-28	ABEO	4.56	0.41	0.13	22262
2026-10-29	ABEO	4.57	0.41	26.00	22298
2026-10-30	ABEO	4.35	0.41	85.83	22390
2026-11-02	ABEO	4.26	0.42	1.81	22552
2026-11-03	ABEO	4.26	0.41	1.97	22820
2026-11-04	ABEO	4.21	0.41	14.43	23130
2026-11-05	ABEO	3.91	0.41	63.33	23166
2026-11-06	ABEO	4.18	0.42	0.58	23274
2026-11-09	ABEO	2.48	0.42	0.57	23312
2026-11-10	ABEO	2.42	0.24	0.49	20634
2026-11-11	ABEO	2.34	0.25	0.01	20906
2026-11-12	ABEO	2.29	0.22	1.94	21683
Date	Symbol	Latest	P/C OI	P/C Vol	Total OI

22 items 1 of 1

22 items of 1

Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year
2026-10-14	ABEO	4.38	-57.4	-	-0.95
2026-10-15	ABEO	4.66	-57.4	-	-0.95
2026-10-16	ABEO	4.44	-57.4	-	-0.95
2026-10-19	ABEO	4.41	-57.4	-	-0.95
2026-10-20	ABEO	4.41	-57.4	-	-0.95
2026-10-21	ABEO	4.60	-57.4	-	-0.95
2026-10-22	ABEO	4.46	-57.4	-	-0.95
2026-10-23	ABEO	4.41	-57.4	-	-0.95
2026-10-26	ABEO	4.32	-57.4	-	-0.95
2026-10-27	ABEO	4.47	-57.4	-	-0.95
2026-10-28	ABEO	4.55	-57.4	-	-0.95
2026-10-29	ABEO	4.57	-57.4	-	-0.95
2026-10-30	ABEO	4.36	-57.4	-	-0.95
2026-11-02	ABEO	4.27	-57.4	-	-0.95
2026-11-03	ABEO	4.26	-57.4	-	-0.95
2026-11-04	ABEO	4.21	-57.4	-	-0.95
2026-11-05	ABEO	3.92	-57.4	-	-0.95
2026-11-06	ABEO	4.17	-57.4	-	-0.95
2026-11-09	ABEO	2.53	-57.4	-	-0.95
2026-11-10	ABEO	2.45	-57.4	-	-0.95
2026-11-11	ABEO	2.29	-57.4	-	-0.95
2026-11-12	ABEO	2.29	-57.4	-	-0.95
Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year

22 items 1 of 1

21 items of 1

Date	Ticker	Insider Transactions	Institutional Transactions	Float Short
2026-10-14	ABEO	-5.38	0.97	33.30
2026-10-15	ABEO	-5.38	0.97	33.30
2026-10-16	ABEO	-5.38	0.97	33.30
2026-10-19	ABEO	-5.38	0.96	33.30
2026-10-20	ABEO	-5.38	0.96	33.30
2026-10-21	ABEO	-5.38	0.96	33.30
2026-10-22	ABEO	-5.38	0.96	33.30
2026-10-23	ABEO	-5.38	0.96	33.30
2026-10-26	ABEO	-5.38	1.01	33.30
2026-10-27	ABEO	-5.38	1.01	33.95
2026-10-28	ABEO	-5.38	1.01	33.95
2026-10-29	ABEO	-5.38	1.01	33.95
2026-10-30	ABEO	-5.38	1.01	33.95
2026-11-02	ABEO	-5.38	1.12	33.95
2026-11-03	ABEO	-5.38	1.12	33.95
2026-11-05	ABEO	-5.38	1.12	33.95
2026-11-06	ABEO	-5.38	1.12	33.95
2026-11-09	ABEO	-5.38	0.75	33.95
2026-11-10	ABEO	-5.38	0.75	33.95
2026-11-11	ABEO	-5.38	0.75	33.29
2026-11-12	ABEO	-5.30	0.75	33.31
Date	Ticker	Insider Transactions	Institutional Transactions	Float Short

21 items 1 of 1

Last Quarter Act. EPS

-0.08

Avg. EPS Est. Current Quarter

-0.17

Avg. EPS Est. Next Quarter

-0.13

Insider Transactions

-5.3

Institutional Transactions

0.75

Beta

1.5

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

90.4

Max Drawdown 5-Year %

-90.4

Target Price

15.56

P/E

Forward P/E

PEG

P/S

3.35

P/B

1.04

P/Free Cash Flow

EPS

-1.11

Average EPS Est. Cur. Y

-0.95

EPS Next Y. (Est.)

-0.21

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

-160.3

Relative Volume

1.44

Return on Equity vs Sector %

-76.1

Return on Equity vs Industry %

-56.6

EPS 1 7Days Diff

-0.1

EPS 1 30Days Diff

-0.08

EBIT Estimation

◆ ABEO Healthcare

$2.29

📉

Swing / Pullback

Buy the dip on strong trends

N/A

WEAK

Trend

10/20

Pullback

11/25

Volume

0/15

Valuation

12/20

TP/AR

2/10

Options

7/10

RSI

14.2

Range 1M

3.6%

Sup Dist

4.4%

🚀

Momentum Growth

Ride accelerating trends

N/A

WEAK

Momentum

12/25

Growth

16/30

Estimates

2/20

Inst/Vol

5/15

Options

5/10

EPS Yr

-196.5%

EPS NY

54.9%

52W%

1.8%

💎

Long-Term Value

Quality companies, undervalued

N/A

WEAK

🟢 BUY +579.5% upside

Quality

5/30

Valuation

16/30

Growth

11/25

Stability

8/10

LT Trend

4/5

Upside

+579.5%

Quality

ABEO — P/E HistoricalBiotechnology

Abeona Therapeutics Inc.

Sector: Healthcare

Industry: Biotechnology

Employees: 226

Abeona Therapeutics Inc., a commercial-stage biopharmaceutical company, develops gene and cell therapies for life-threatening diseases in the United States. It develops ZEVASKYN, an autologous, cell-based gene therapy for the treatment of patients with recessive dystrophic epidermolysis bullosa. The company also develops ABO-503 to treat X-linked retinoschisis; ABO-504 for the treatment of stargardt disease; and ABO-505 to treat autosomal dominant optic atrophy. In addition, it is developing AAV-based gene therapy through its AIM vector platform programs. The company was formerly known as PlasmaTech Biopharmaceuticals, Inc. and changed its name to Abeona Therapeutics Inc. in June 2015. Abeona Therapeutics Inc. was founded in 1974 and is headquartered in Cleveland, Ohio.

ABEO

Latest News

—

Caricamento notizie per ABEO…

stock quote shares ABEO – Abeona Therapeutics Inc Stock Price stock today

news today ABEO – Abeona Therapeutics Inc stock forecast ,stock prediction 2023 2024 2025

marketwatch ABEO – Abeona Therapeutics Inc yahoo finance google finance

stock history ABEO – Abeona Therapeutics Inc invest stock market

stock prices ABEO premarket after hours

ticker ABEO fair value insiders trading

Float Short %

Margin Of Safety %

Put/Call OI Ratio

EPS Next Q Diff

EPS Last/This Y

EPS This/Next Y

Price

Target Price

Analyst Recom

Performance Q

Upside

Beta

Ticker: ABEO

Last Quarter Act. EPS​

Avg. EPS Est. Current Quarter

Avg. EPS Est. Next Quarter

Insider Transactions

Institutional Transactions

Beta

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

Max Drawdown 5-Year %

Target Price

P/E

Forward P/E

PEG

P/S

P/B

P/Free Cash Flow

EPS

Average EPS Est. Cur. Y​

EPS Next Y. (Est.)

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

Relative Volume

Return on Equity vs Sector %

Return on Equity vs Industry %

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

Latest News

Last Quarter Act. EPS

Average EPS Est. Cur. Y